Search

Displaying results 2651 - 2660 of 7284 in total
  1. Drug

    Sulfaloxic acid

    go.drugbank.com/drugs/DB19971
    Experimental

    Sulfaloxic acid is a small molecule drug. Sulfaloxic acid has a monoisotopic molecular weight of 393.06 Da.

  2. Drug

    Sorbitan tristearate

    go.drugbank.com/drugs/DB20134
    Experimental

    Sorbitan tristearate is a small molecule drug. Sorbitan tristearate has a monoisotopic molecular weight of 962.85 Da.

  3. Drug

    Sorbitan monolaurate

    go.drugbank.com/drugs/DB20157
    Investigational

    Sorbitan monolaurate is a small molecule drug. Sorbitan monolaurate has a monoisotopic molecular weight of 346.24 Da.

  4. Drug

    Sorbitan monopalmitate

    go.drugbank.com/drugs/DB20199
    Experimental

    Sorbitan monopalmitate is a small molecule drug. Sorbitan monopalmitate has a monoisotopic molecular weight of 402.3 Da.

  5. Drug

    Iomeglamic acid

    go.drugbank.com/drugs/DB21167
    Experimental

    Iomeglamic acid is a small molecule drug. Iomeglamic acid has a monoisotopic molecular weight of 613.81 Da.

  6. Drug

    Kainic acid

    go.drugbank.com/drugs/DB21189
    Experimental

    Kainic acid is a small molecule drug. Kainic acid has a monoisotopic molecular weight of 213.1 Da.

  7. Drug

    Dexamethasone acefurate

    go.drugbank.com/drugs/DB21317
    Experimental

    Dexamethasone acefurate is a small molecule drug. Dexamethasone acefurate has a monoisotopic molecular weight of 528.22 Da.

  8. Drug

    Tiazotic acid

    go.drugbank.com/drugs/DB21408
    Experimental

    Tiazotic acid is a small molecule drug. Tiazotic acid has a monoisotopic molecular weight of 173.03 Da.

  9. Drug

    Oxiniacic acid

    go.drugbank.com/drugs/DB21422
    Experimental

    Oxiniacic acid is a small molecule drug. Oxiniacic acid has a monoisotopic molecular weight of 139.03 Da.

  10. Drug

    Tolvaptan

    go.drugbank.com/drugs/DB06212
    ApprovedInvestigational

    FDA approved on May 19, 2009.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index